MSD is also bracing for a $200m hit due to tariffs as it accelerates US manufacturing and shifts its global supply strategy.

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...

Merck & Co. said it expects to lose $200 million to already-announced tariffs in 2025 amid an escalating trade war between ...

The company’s stock fell as much as 2.8% after markets opened in New York Thursday. For the first quarter, Merck’s results ...

Find insight on Merck, Sanofi and more in the latest Market Talks covering the Health Care sector.

Merck stock reversed higher Thursday, though the company reported another quarter of light sales for its HPV vaccine, ...

Why it matters: Investors have been particularly concerned about demand for HPV vaccine Gardasil in China, with uncertainty around pharmaceutical tariffs also weighing on shares. Gardasil's 41% ($ ...

Merck & Co. said it expects to lose $200 million to already-announced tariffs in 2025 amid an escalating trade war between the US and China, where demand for its blockbuster Gardasil vaccine is ...

On an earnings call in February, he answered question after question about plunging demand for his company’s vaccine against ...

In its first-quarter results update, MSD – which is known as Merck & Co in the US and Canada – said it expects full-year ...